Figure 1 | Leukemia

Figure 1

From: Clinical impact of bone marrow morphology for the diagnosis of essential thrombocythemia: comparison between the BCSH and the WHO criteria

Figure 1

(a–d) Kaplan–Meier estimates of fibrosis-free survival and overall survival with significant differences in 232 WHO-confirmed versus 238 BCSH-defined ET patients (Figures a and b). Separate analysis of the WHO-diagnosed prePMF fraction of 77 patients included in the BCSH-classified ET cohort of 238 patients reveals a significant worsening of fibrosis-free and overall survival (Figures c and d). Abbreviation: CI, confidence interval.

Back to article page